Latest News about MRK
Recent news which mentions MRK
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
November 22, 2022
From Benzinga
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
From Benzinga
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
November 21, 2022
From Motley Fool
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
November 21, 2022
From InvestorPlace
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
November 21, 2022
From Benzinga
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
November 20, 2022
From Benzinga
The 25 Best Stocks to Buy for Retirement
November 19, 2022
From InvestorPlace
2 Top Biotech Stocks to Buy Right Now
November 19, 2022
From Motley Fool
3 Bargain Stocks You Can Buy Today and Hold Forever
November 18, 2022
From Motley Fool
Credit Suisse Believes In This Pharma Giant's Low Risk Growth Against Uncertain Backdrop
November 18, 2022
Tickers
MRK
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 18, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial
November 17, 2022
From Benzinga
How Long Can This Top Stock Continue Defying the Bear Market?
November 17, 2022
From Motley Fool
4 Reasons to Buy This Hybrid of a Growth and Income Stock
November 17, 2022
Tickers
MRK
From Motley Fool
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
7 Value Stocks to Buy Before They Pop Off
November 15, 2022
From InvestorPlace
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
From Benzinga
These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk
November 11, 2022
From Benzinga
Why Are Healthcare Stocks Down Today?
November 11, 2022
From InvestorPlace
SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients
November 10, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.